List view / Grid view
Charlotte Walker-Osborn, a Partner and Head of Technology Sector (International) at global law-firm Eversheds Sutherland and a legal expert in technology law, explains some of the challenges and potential future of artificial intelligence (AI) in the field of drug discovery.
22 June 2016 | By Victoria White, Digital Content Producer
Four cancer centres in the US are coming together in a new consortium to accelerate the discovery and development of novel cancer therapeutics...
6 October 2015 | By Victoria White
Frost & Sullivan have found that non-therapeutic use of human albumin as an excipient has generated plenty of interest across the industry...
9 July 2015 | By Victoria White
Epizyme has amended and restated its agreement with Celgene to extend their research collaboration for at least three additional years...
30 June 2015 | By Victoria White
Celgene and Juno Therapeutics have entered into a global collaboration for the development and commercialisation of immunotherapies...
10 June 2015 | By Victoria White
Lycera has formed of an exclusive global collaboration with Celgene to take forward Lycera's proprietary pipeline for cancer and immune-mediated diseases...
4 June 2015 | By Victoria White
The existing global collaboration between Celgene and bluebird bio has been amended and restated to focus on developing product candidates targeting BCMA...
